Cutaneous Sarcoidosis: Management & Therapeutics

The focus of this presentation is on the management and therapeutics of cutaneous sarcoidosis. The speaker emphasizes the importance of a multidisciplinary approach when treating patients with both systemic and skin manifestations of the disease. A case study of a 50-year-old woman with cutaneous sarcoidosis, presenting with indurated pink nodular plaques on her face, is discussed. After failing previous treatments, her care involves collaboration with pulmonologists, cardiologists, and ophthalmologists. The speaker outlines various therapeutic options including topical and systemic medications such as corticosteroids, methotrexate, TNF inhibitors, and JAK inhibitors like tofacitinib, which have shown effectiveness in improving skin lesions. The management strategy is individualized based on the severity of the skin and systemic involvement, patient well-being, and response to therapy. The discussion also covers the importance of monitoring for potential side effects of treatments, especially when prescribing JAK inhibitors. Ultimately, the presentation advocates for a team-based approach to effectively manage sarcoidosis, ensuring thorough evaluations and collaborative decision-making among specialists.